These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11184272)

  • 1. Cost-effectiveness studies: are they always cost effective?
    Kozma CM
    Manag Care Interface; 1999 Nov; 12(11):64-5. PubMed ID: 11184272
    [No Abstract]   [Full Text] [Related]  

  • 2. Looking beyond cost.
    Scott L
    Mod Healthc; 1994 Feb; 24(9):36-8, 40. PubMed ID: 10131992
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effectiveness research.
    Pentecost MJ
    J Am Coll Radiol; 2009 Aug; 6(8):547-8. PubMed ID: 19643380
    [No Abstract]   [Full Text] [Related]  

  • 4. Global cost-effectiveness of cataract surgery.
    Lansingh VC; Carter MJ; Martens M
    Ophthalmology; 2007 Sep; 114(9):1670-8. PubMed ID: 17383730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Debate about funding comparative-effectiveness research.
    Avorn J
    N Engl J Med; 2009 May; 360(19):1927-9. PubMed ID: 19420361
    [No Abstract]   [Full Text] [Related]  

  • 6. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
    Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
    Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness issues and research studies.
    Neumann BR
    J Long Term Care Adm; 1983; 11(3):48-53. PubMed ID: 10310289
    [No Abstract]   [Full Text] [Related]  

  • 8. Value-chain analysis of a rural health program: toward understanding the cost benefit of telemedicine applications.
    Gamble JE; Savage GT; Icenogle ML
    Hosp Top; 2004; 82(1):10-7. PubMed ID: 15490956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroblastoma, well-designed evaluations, and the optimality of research funding: ask not what your country can do for you ..
    Levy IG
    J Natl Cancer Inst; 2005 Aug; 97(15):1105-6. PubMed ID: 16077062
    [No Abstract]   [Full Text] [Related]  

  • 10. The value of pharmaceuticals--some direction for employers.
    Goetzel RZ; Ozminkowski RJ; Schutt DC
    Empl Benefits J; 2002 Sep; 27(3):31-5. PubMed ID: 12219561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The death of cost-minimization analysis?
    Briggs AH; O'Brien BJ
    Health Econ; 2001 Mar; 10(2):179-84. PubMed ID: 11252048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacoeconomics.
    Ahuja J; Gupta M; Gupta AK; Kohli K
    Natl Med J India; 2004; 17(2):80-3. PubMed ID: 15141600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary on "Opportunities and challenges for measuring cost, quality, and clinical effectiveness in health care": the fault lies not in our stars but in our system.
    Saver BG
    Med Care Res Rev; 2004 Sep; 61(3 Suppl):151S-60S. PubMed ID: 15375290
    [No Abstract]   [Full Text] [Related]  

  • 14. Opportunities and challenges for measuring cost, quality, and clinical effectiveness in health care.
    Fishman PA; Hornbrook MC; Meenan RT; Goodman MJ
    Med Care Res Rev; 2004 Sep; 61(3 Suppl):124S-43S. PubMed ID: 15375288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives. Effectiveness: another name for cost control?
    Wiener JO
    Mcgraw Hills Med Health; 1989 Oct; 43(40):suppl 4 p.. PubMed ID: 10313331
    [No Abstract]   [Full Text] [Related]  

  • 16. The economic analysis of prevention: an illustration involving children's behavior problems.
    Foster EM; Jones DE
    J Ment Health Policy Econ; 2007 Dec; 10(4):165-75. PubMed ID: 18166828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of terminology and methodology in economic analyses in otolaryngology.
    Kezirian EJ; Yueh B
    Otolaryngol Head Neck Surg; 2001 May; 124(5):496-502. PubMed ID: 11337651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of treating ocular hypertension.
    Stewart WC; Stewart JA; Nasser QJ; Mychaskiw MA
    Ophthalmology; 2008 Jan; 115(1):94-8. PubMed ID: 18166406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of patients with ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study.
    Rosenbaum LJ
    Am J Ophthalmol; 2007 Jan; 143(1):191-2; author reply 192-3. PubMed ID: 17188074
    [No Abstract]   [Full Text] [Related]  

  • 20. Services integration and cost-effectiveness.
    Hilton ME; Fleming M; Glick H; Gutman MA; Lu Y; McKay J; McLellan AT; Manning W; Meadows J; Mertens JR; Moore C; Mullahy J; Mundt M; Parthasarathy S; Polsky D; Ray GT; Sterling S; Weisner C
    Alcohol Clin Exp Res; 2003 Feb; 27(2):271-80. PubMed ID: 12605076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.